| Financial Year |
September 30 2018 |
| Monetary Funds |
5,276,537,201.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,680,709.25 |
| Accounts Receivable |
1,074,072,776.00 |
| Advances to Suppliers |
139,562,993.91 |
| Other Receivables |
217,589,496.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
29,842,985.86 |
| Dividend Receivable |
432,425.19 |
| Inventories |
11,696,849.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,355,998.01 |
| Total Current Assets |
6,774,496,025.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,315,863,758.01 |
| Investment Properties |
249,062,888.90 |
| Fixed Assetes |
888,989,265.68 |
| Under-construction Projects |
302,350,553.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
459,005,957.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,059,764.40 |
| Deferred Income Tax Assets |
47,644,614.12 |
| Other Non-Current Assets |
25,248,000.00 |
| Sub-Total of Non-Current Assets |
3,526,466,767.00 |
| Total Assets |
10,300,962,792.40 |
| Short-Term Loans |
83,001,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,883,090.97 |
| Taxes Payable |
45,096,435.99 |
| Interest Payable |
250,287.56 |
| Dividend Payable |
-- |
| Other payables |
75,332,576.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
77,588,500.00 |
| Sub-Total of Current Liabilities |
1,824,340,973.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,224,049.97 |
| Total Liabilities |
1,857,565,023.66 |
| Paid-In Capital(Or Share Stock) |
905,481,720.00 |
| Capital Surplus |
538,471,957.88 |
| Surplus Reserve |
490,091,875.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,467,847,510.16 |
| Minority Stockholder's Interest |
5,363,858.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,438,033,910.33 |
| Owner's Equity（Stockholder's Equity） |
8,443,397,768.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,300,962,792.40 |
